Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ACT001
Description:
ACT001 is an experimental small-molecule drug studied for anti-inflammatory and antitumor effects in biomedical research.
Primary topic:
Glioma Diagnosis and Treatment (23%)
Related topics:
Glioma Diagnosis and Treatment (23%),
Traumatic Brain Injury and Neurovascular Disturbances (9%),
Sesquiterpenes and Asteraceae Studies (8%)
OpenAlex ID:
keywords/act001
ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway
2022
·
Lin Cai
, Qiuyuan Gong
, et al.
·
Cell Communication and Signaling
·
179
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
2020
·
Luqing Tong
, Jiabo Li
, et al.
·
Theranostics
·
177
ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma
2019
·
Xiaonan Xi
, Ning Liu
, et al.
·
Cell Death and Disease
·
159
PDF
Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling
2020
·
Yanli Hou
, Bowen Sun
, et al.
·
Theranostics
·
76
ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth
2020
·
Qiuying Li
, Yu Sun
, et al.
·
Journal of Molecular Medicine
·
59
Pharmacokinetics, tissue distribution and excretion of ACT001 in Sprague-Dawley rats and metabolism of ACT001
2018
·
Xiao-Nan Xi
, Ning Liu
, et al.
·
Journal of Chromatography B
·
52
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis
2021
·
Jade Jaffar
, Ian Glaspole
, et al.
·
Biomedicine & Pharmacotherapy
·
50
PDF
The parthenolide derivative ACT001 synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson’s disease in mice
2019
·
Qianqian Liu
, Shaozhi Zhang
, et al.
·
Behavioural Brain Research
·
45
ACT001 Ameliorates ionizing radiation-induced lung injury by inhibiting NLRP3 inflammasome pathway
2023
·
Hao Luo
, Xiaoming Liu
, et al.
·
Biomedicine & Pharmacotherapy
·
39
ACT001 suppressing M1 polarization against inflammation via NF-κB and STAT1 signaling pathways alleviates acute lung injury in mice
2022
·
Hui Guo
, Yan Song
, et al.
·
International Immunopharmacology
·
38
Production of Plant Sesquiterpene Lactone Parthenolide in the Yeast Cell Factory
2022
·
Yiting Shi
, Tianyu Dong
, et al.
·
ACS Synthetic Biology
·
35
Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 inflammasome in MPTP-induced Parkinson disease in mice
2020
·
Qianqian Liu
, Xinyang Guo
, et al.
·
Behavioural Brain Research
·
31
ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation
2018
·
Xiao‐Han Jin
, Yong‐Sheng Jia
, et al.
·
Journal of Cellular Biochemistry
·
30
ACT001 Inhibits TLR4 Signaling by Targeting Co-Receptor MD2 and Attenuates Neuropathic Pain
2022
·
Tianshu Zhang
, Cong Lin
, et al.
·
Frontiers in Immunology
·
27
Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1
2020
·
Yanyang Liu
, Li Wang
, et al.
·
Cancer Management and Research
·
26
PDF
Phase 1 dose-escalation study of ACT001 in patients with recurrent glioblastoma and other advanced solid tumors.
2018
·
Jason D. Lickliter
, Ross Jennens
, et al.
·
Journal of Clinical Oncology
·
23
ACT001 inhibits pituitary tumor growth by inducing autophagic cell death via MEK4/MAPK pathway
2022
·
Lin Cai
, Ze-rui Wu
, et al.
·
Acta Pharmacologica Sinica
·
22
PDF
ACT001 alleviates inflammation and pyroptosis through the PPAR-γ/NF-κB signaling pathway in LPS-induced alveolar macrophages
2023
·
Qiang Fu
, Na Shen
, et al.
·
Genes & Genomics
·
21
ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43/AMPK pathway
2023
·
Yibing Zhou
, Ze Chen
, et al.
·
Lipids in Health and Disease
·
19
PDF
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways
2021
·
Junhao Zhu
, Chao Tang
, et al.
·
Endocrine Related Cancer
·
18
PDF
Phase 1 dose-escalation study of ACT001 in patients with recurrent glioblastoma and other advanced solid tumors.
2021
·
Jason D. Lickliter
, Ross Jennens
, et al.
·
Journal of Clinical Oncology
·
18
ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity
2025
·
Xiao‐Jing Ding
, Ting Mei
, et al.
·
Thoracic Cancer
·
17
PDF
ACT001 improves OVX-induced osteoporosis by suppressing the NF-κB/NLRP3 signaling pathway
2025
·
Yuan Li
, Jin-Yu Yang
, et al.
·
Molecular Medicine
·
15
PDF
ACT001 improved cardiovascular function in septic mice by inhibiting the production of proinflammatory cytokines and the expression of JAK-STAT signaling pathway
2023
·
Zhen Peng
, Xiaolong Lv
, et al.
·
Frontiers in Pharmacology
·
13
PDF
ACT001 inhibits the proliferation of non‐small cell lung cancer cells by upregulating NKTR expression
2022
·
Min Zhao
, Tingting Qin
, et al.
·
Thoracic Cancer
·
13
Show more works
View as search
Works count:
87
Citation count:
1,333
Year
Topic
Type